2018

Active Lymphoedema Device

Ultrasound technology to move fluids within the body

Dialysis system

A breakthrough dialysis machine that can be used at home or by rural health workers in remote settings

iFix

Novel medical treatment technology that incorporates 3D printing for corneal diseases and injuries

Indee

Developing hardware for gene delivery

Kico Knee

Customised total knee replacement technology platform

Trimph

Platform technology to repair bone, cartilage and connective tissues

Developing recombinant human platelet-derived growth factor-AB as a novel cardiac regenerative therapy

Validating the safety of Platelet Derived Growth Factor to improve the heart function

Establishment of novel therapies for pulmonary hypertension

Studying new mechanisms that may be involved in a disease that results in increase in blood pressure in the lungs.

Improving genetic diagnosis in congenital heart disease

Increasing the genetic diagnosis of heart defects will help more families receive an accurate genetic diagnosis, personalised advice concerning the disease in their family and a better estimate of the risk of having a subsequent child with a heart defect

The safety, effectiveness and utilisation of smoking cessation pharmacotherapies among smokers hospitalised for a cardiovascular event in NSW

Determining which of three medicines is most likely to have the greatest long term benefit for cardiac patients, and the extent to which each of these medicines are currently used by cardiac patients after discharge from NSW hospitals

Clinical and genetic aspects of hypertrophic cardiomyopathy

Reassessment of risk algorithms in a more homogeneous patient population will allow development of accurate risk prediction scores

Advanced cardiac imaging techniques in the management of acute chest pain and related health services delivery

Develop new insights into health service of acute chest pain by the application and development of these state-of-the-art investigations to create a paradigm shift in chest pain management and improve healthcare costs

Catheter ablation versus antiarrhythmic drugs for ventricular tachycardia in non-ischemic cardiomyopathy

A randomised trial that will examine if catheter ablation is superior to anti-arrhythmic medication in the treatment of ventricular tachycardia in patients with non-ischemic cardiomyopathy

Targeting procoagulant platelets in cardiovascular disease

Investigating the link between procoagulant platelets, platelet mitochondrial function and cardiovascular disease

Live imaging endothelial-immune interactions in atherogenesis

Use see-through zebrafish to literally shed new light on what happens in atherosclerotic plaques using microscopy of the disease inside living zebrafish

STUPENDIS

Steps towards understanding and preventing early neurological deterioration in ischaemic stroke

Developing and validating a new assay for the detection and prediction of gardiometabolic disease

Develop and validate a blood test that can be widely used, e.g. hospital outpatients, and general practitioner offices, to detect a new molecule in blood

Implementation of strategies for early detection and prevention of chemotherapy-induced cardiotoxicity in cancer patients

Discovering simple blood test(s) that could detect early onset of chemotherapy-induced cardiotoxicity as well as providing better education and facilitating self-care and empowerment for cancer patients/survivors

Developing CAR T cells and gene viral vectors rapidly for paediatric trials for cancer, eye and kidney disease

Develop CAR T cells to target a broad range of paediatric tumours, and CAR T cells to protect kidney transplants from chronic allograft nephropathy, as well as gene viral vectors to target blinding eye disease and to treat childhood kidney disease

A randomised trial of cell therapy for opportunistic infection after allogeneic stem cell transplant

Test the theory that adding cell therapy to standard antibiotic treatment for infection in patients after bone marrow transplant will improve the immune system leading to better control of serious infections, less serious illness and fewer deaths

Developing a stem cell-based therapy for chronic pain

Developed a long-lasting stem cell therapy that can reverse neuropathic pain

Receptor identification of AAV capsids purposed for gene therapeutic use

Identify genetic variants that may affect receptor expression and enable us to screen patients for those who will be better responders

Uncovering novel mechanosensing pathways that underlie cardiac arrhythmias

Identifying new cellular pathways underlying arrhythmia generation by evaluating how mechanical stress affects the cells that line the chambers of the heart

Online treatment program for postnatal depression and anxiety

Reaching women in underserviced communities in NSW: An online treatment program

FIT HEART

Feasibility of an intervention targeting health through exergaming as an alternative to routine treatment

Evaluating Time2BHealthy

Evaluating an on-line healthy eating and active living support program (Time2BHealthy) for parents of 2-6 year children

SWAP-It

Swap what’s packed in the lunchbox

BEEM-HF Randomised Controlled Trial

Improving outcomes following hospitalisation for heart failure in regional and remote NSW

Optimising timing of planned birth to improve newborn outcomes

Are we there yet?: Optimising timing of planned birth to improve newborn outcomes and reduce health service costs

Online cognitive behavioural therapy for bulimia nervosa

A randomised controlled trial of guided online cognitive behavioural therapy, compared to a waitlist control

eADVICE

Advice while you wait: Empowering families, improving health, reducing waiting times

Healthy hearts

Development and evaluation of an outreach, family centred model of cardiac rehabilitation for Aboriginal people

Management of rural acute coronary syndrome

Defining a new paradigm for assessment and management of acute coronary syndromes (ACS) in rural settings utilising a central clinical decision support service

Centralised management system and hot transfer for STEMI

Non-randomised, prospective, controlled trial of a centralised, district-wide STEMI management system implemented by NSW ambulance and all hospitals within the Western NSW Local Health District

Back to top